search button

Effects on host of modified PVP therapy combined with biological response modifiers in lung cancer.

  • Authors:
    • R Katoh
    • S Takenoshita
    • Y Shimizu
    • S Tanaka
    • Y Yajima
    • Y Nagamachi

  • View Affiliations

  • Published online on: January 1, 1998     https://doi.org/10.3892/or.5.1.103
  • Pages: 103-110
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

We relieved several side effects by modifying chemotherapy and concurrently using biological response modifiers (BRMs) to experimentally and clinically investigate treatment, which can maintain quality of life (QOL) for lung cancer patients including changes in systemic immune capacity. sIL-2R levels are useful for predicting the course after recurrence. Immunosuppressive acid protein (IAP) levels are useful for detecting the presence or absence of recurrence and for predicting prognosis. BRMs are useful for continuing modified PVP (CDDP + VP-16) therapy, and sIL-2R and IAP levels for clarifying host conditions.

Related Articles

Journal Cover

Jan-Feb 1998
Volume 5 Issue 1

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 4.2
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 8.4
  • CiteScore Rank: Q1: #68/366 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.786
  • SCImago Journal Rank (SJR): 0.812
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Katoh R, Takenoshita S, Shimizu Y, Tanaka S, Yajima Y and Nagamachi Y: Effects on host of modified PVP therapy combined with biological response modifiers in lung cancer.. Oncol Rep 5: 103-110, 1998
APA
Katoh, R., Takenoshita, S., Shimizu, Y., Tanaka, S., Yajima, Y., & Nagamachi, Y. (1998). Effects on host of modified PVP therapy combined with biological response modifiers in lung cancer.. Oncology Reports, 5, 103-110. https://doi.org/10.3892/or.5.1.103
MLA
Katoh, R., Takenoshita, S., Shimizu, Y., Tanaka, S., Yajima, Y., Nagamachi, Y."Effects on host of modified PVP therapy combined with biological response modifiers in lung cancer.". Oncology Reports 5.1 (1998): 103-110.
Chicago
Katoh, R., Takenoshita, S., Shimizu, Y., Tanaka, S., Yajima, Y., Nagamachi, Y."Effects on host of modified PVP therapy combined with biological response modifiers in lung cancer.". Oncology Reports 5, no. 1 (1998): 103-110. https://doi.org/10.3892/or.5.1.103